Skip to main content
Erschienen in: Digestive Diseases and Sciences 4/2024

06.03.2024 | Multicenter Seminars: IBD (MUSE: IBD)

Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis

verfasst von: Arafa Djalal, Serre-Yu Wong, Jean-Frédéric Colombel, Ryan Ungaro, Maia Kayal

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Excerpt

A 33-year-old woman with ulcerative colitis (UC) status post ileal pouch-anal anastomosis (IPAA) was evaluated for complaints of swelling of the left gluteal cleft accompanied by spontaneous purulent drainage. …
Literatur
1.
Zurück zum Zitat Murphy PB, Khot Z, Vogt KN, Ott M, Dubois L. Quality of life after total proctocolectomy with ileostomy or IPAA: a systematic review. Dis Colon Rectum 2015;58:899–908.CrossRefPubMed Murphy PB, Khot Z, Vogt KN, Ott M, Dubois L. Quality of life after total proctocolectomy with ileostomy or IPAA: a systematic review. Dis Colon Rectum 2015;58:899–908.CrossRefPubMed
2.
Zurück zum Zitat Shen B, Kochhar GS, Kariv R et al. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol 2021;6:826–849.CrossRefPubMed Shen B, Kochhar GS, Kariv R et al. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol 2021;6:826–849.CrossRefPubMed
3.
Zurück zum Zitat Barnes EL, Kochar B, Jessup HR, Herfarth HH. The incidence and definition of Crohn’s disease of the pouch: a systematic review and meta-analysis. Inflamm Bowel Dis 2019;25:1474–1480.CrossRefPubMedPubMedCentral Barnes EL, Kochar B, Jessup HR, Herfarth HH. The incidence and definition of Crohn’s disease of the pouch: a systematic review and meta-analysis. Inflamm Bowel Dis 2019;25:1474–1480.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Kayal M, Kohler D, Plietz M et al. Early pouchitis is associated with Crohn’s disease-like pouch inflammation in patients with ulcerative colitis. Inflamm Bowel Dis 2022;28:1821–1825.CrossRefPubMedPubMedCentral Kayal M, Kohler D, Plietz M et al. Early pouchitis is associated with Crohn’s disease-like pouch inflammation in patients with ulcerative colitis. Inflamm Bowel Dis 2022;28:1821–1825.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Shen B, Remzi FH, Lavery IC, Lashner BA, Fazio VW. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol 2008;6:145–158; quiz 124.CrossRefPubMed Shen B, Remzi FH, Lavery IC, Lashner BA, Fazio VW. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol 2008;6:145–158; quiz 124.CrossRefPubMed
6.
Zurück zum Zitat Fazio VW, Kiran RP, Remzi FH et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013;257:679–685.CrossRefPubMed Fazio VW, Kiran RP, Remzi FH et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013;257:679–685.CrossRefPubMed
7.
Zurück zum Zitat Nisar PJ, Kiran RP, Shen B, Remzi FH, Fazio VW. Factors associated with ileoanal pouch failure in patients developing early or late pouch-related fistula. Dis Colon Rectum 2011;54:446–453.CrossRefPubMed Nisar PJ, Kiran RP, Shen B, Remzi FH, Fazio VW. Factors associated with ileoanal pouch failure in patients developing early or late pouch-related fistula. Dis Colon Rectum 2011;54:446–453.CrossRefPubMed
8.
Zurück zum Zitat Choi YS, Lee DH, Lee JB et al. Clinical characteristics and incidence of perianal diseases in patients with ulcerative colitis. Ann Coloproctol 2018;34:138–143.CrossRefPubMedPubMedCentral Choi YS, Lee DH, Lee JB et al. Clinical characteristics and incidence of perianal diseases in patients with ulcerative colitis. Ann Coloproctol 2018;34:138–143.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Gaertner WB, Witt J, Madoff RD et al. Ileal pouch fistulas after restorative proctocolectomy: management and outcomes. Tech Coloproctol 2014;18:1061–1066.CrossRefPubMed Gaertner WB, Witt J, Madoff RD et al. Ileal pouch fistulas after restorative proctocolectomy: management and outcomes. Tech Coloproctol 2014;18:1061–1066.CrossRefPubMed
11.
Zurück zum Zitat Tekkis PP, Fazio VW, Remzi F, Heriot AG, Manilich E, Strong SA. Risk factors associated with ileal pouch-related fistula following restorative proctocolectomy. Br J Surg 2005;92:1270–1276.CrossRefPubMed Tekkis PP, Fazio VW, Remzi F, Heriot AG, Manilich E, Strong SA. Risk factors associated with ileal pouch-related fistula following restorative proctocolectomy. Br J Surg 2005;92:1270–1276.CrossRefPubMed
12.
Zurück zum Zitat Heimann TM, Swaminathan S, Slater GI, Kurtz RJ. Perianal fistula after ileoanal pouch in patients with ulcerative colitis: a review of 475 patients operated on at a major IBD Center. Dis Colon Rectum 2022;65:76–82.CrossRefPubMed Heimann TM, Swaminathan S, Slater GI, Kurtz RJ. Perianal fistula after ileoanal pouch in patients with ulcerative colitis: a review of 475 patients operated on at a major IBD Center. Dis Colon Rectum 2022;65:76–82.CrossRefPubMed
13.
Zurück zum Zitat Heriot AG, Tekkis PP, Smith JJ, Bona R, Cohen RG, Nicholls JR. Management and outcome of pouch-vaginal fistulas following restorative proctocolectomy. Dis Colon Rectum 2005;484:451–458.CrossRef Heriot AG, Tekkis PP, Smith JJ, Bona R, Cohen RG, Nicholls JR. Management and outcome of pouch-vaginal fistulas following restorative proctocolectomy. Dis Colon Rectum 2005;484:451–458.CrossRef
14.
Zurück zum Zitat Chin Koon Siw K, Engel J, Visva S et al. Strategies to distinguish perianal fistulas related to Crohn’s disease from cryptoglandular disease: systematic review with meta-analysis. Inflamm Bowel Dis 2022;284:1363–1374.CrossRef Chin Koon Siw K, Engel J, Visva S et al. Strategies to distinguish perianal fistulas related to Crohn’s disease from cryptoglandular disease: systematic review with meta-analysis. Inflamm Bowel Dis 2022;284:1363–1374.CrossRef
15.
Zurück zum Zitat Zhou Z, Ouboter LF, Peeters KC et al. Crohn’s disease-associated and cryptoglandular fistulas: differences and similarities. J Clin Med 2023;12:466.CrossRefPubMedPubMedCentral Zhou Z, Ouboter LF, Peeters KC et al. Crohn’s disease-associated and cryptoglandular fistulas: differences and similarities. J Clin Med 2023;12:466.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Reza LM, Lung PF, Lightner AL, Hart AL, Clark SK, Tozer PJ. Perianal fistula and the ileoanal pouch - different aetiologies require distinct evaluation. Colorectal Dis 2020;22:1436–1439.CrossRefPubMed Reza LM, Lung PF, Lightner AL, Hart AL, Clark SK, Tozer PJ. Perianal fistula and the ileoanal pouch - different aetiologies require distinct evaluation. Colorectal Dis 2020;22:1436–1439.CrossRefPubMed
17.
Zurück zum Zitat Gecim IE, Wolff BG, Pemberton JH, Devine RM, Dozois RR. Does technique of anastomosis play any role in developing late perianal abscess or fistula? Dis Colon Rectum 2000;43:1241–1245.CrossRefPubMed Gecim IE, Wolff BG, Pemberton JH, Devine RM, Dozois RR. Does technique of anastomosis play any role in developing late perianal abscess or fistula? Dis Colon Rectum 2000;43:1241–1245.CrossRefPubMed
18.
Zurück zum Zitat Present DH, Rutgeerts P, Targan S et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 1999;340:1398–1405.CrossRefPubMed Present DH, Rutgeerts P, Targan S et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 1999;340:1398–1405.CrossRefPubMed
19.
Zurück zum Zitat Sands BE, Anderson FH, Bernstein CN et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 2004;350:876–885.CrossRefPubMed Sands BE, Anderson FH, Bernstein CN et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 2004;350:876–885.CrossRefPubMed
20.
Zurück zum Zitat Colombel JF, Sandborn WJ, Rutgeerts P et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn’s disease: the CHARM trial. Gastroenterology 2007;132:52–65.CrossRefPubMed Colombel JF, Sandborn WJ, Rutgeerts P et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn’s disease: the CHARM trial. Gastroenterology 2007;132:52–65.CrossRefPubMed
21.
Zurück zum Zitat Shen B, Kochhar GS, Rubin DT et al. Treatment of pouchitis, Crohn’s disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatolvol. 2022;7:69–95.CrossRef Shen B, Kochhar GS, Rubin DT et al. Treatment of pouchitis, Crohn’s disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatolvol. 2022;7:69–95.CrossRef
22.
Zurück zum Zitat Yarur AJ, Kanagala V, Stein DJ et al. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn’s disease. Aliment Pharmacol Ther 2017;45:933–940.CrossRefPubMed Yarur AJ, Kanagala V, Stein DJ et al. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn’s disease. Aliment Pharmacol Ther 2017;45:933–940.CrossRefPubMed
23.
Zurück zum Zitat Plevris N, Jenkinson PW, Arnott ID, Jones GR, Lees CW. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn’s disease. Eur J Gastroenterol Hepatol 2020;32:32–37.CrossRefPubMed Plevris N, Jenkinson PW, Arnott ID, Jones GR, Lees CW. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn’s disease. Eur J Gastroenterol Hepatol 2020;32:32–37.CrossRefPubMed
24.
Zurück zum Zitat Lightner AL, Pemberton JH, Loftus EJ Jr. Crohn’s disease of the ileoanal pouch. Inflamm Bowel Dis 2016;22:1502–1528.CrossRefPubMed Lightner AL, Pemberton JH, Loftus EJ Jr. Crohn’s disease of the ileoanal pouch. Inflamm Bowel Dis 2016;22:1502–1528.CrossRefPubMed
25.
Zurück zum Zitat Attauabi M, Burisch J, Seidelin JB. Efficacy of ustekinumab for active perianal fistulizing Crohn’s disease: a systematic review and meta-analysis of the current literature. Scand J Gastroenterol 2021;56:53–58.CrossRefPubMed Attauabi M, Burisch J, Seidelin JB. Efficacy of ustekinumab for active perianal fistulizing Crohn’s disease: a systematic review and meta-analysis of the current literature. Scand J Gastroenterol 2021;56:53–58.CrossRefPubMed
27.
Zurück zum Zitat Colombel JF, Irving P, Rieder F et al. P491 efficacy and safety of upadacitinib for the treatment of fistulas and fissures in patients with Crohn’s disease. J Crohns Colitis 2023;17:i620–i623.CrossRef Colombel JF, Irving P, Rieder F et al. P491 efficacy and safety of upadacitinib for the treatment of fistulas and fissures in patients with Crohn’s disease. J Crohns Colitis 2023;17:i620–i623.CrossRef
28.
Zurück zum Zitat Lansdorp CA, Buskens CJ, Gecse KB et al. Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn’s disease: results of the HOT-TOPIC trial after 1-year follow-up. United Eur Gastroenterol J 2022;10:160–168.CrossRef Lansdorp CA, Buskens CJ, Gecse KB et al. Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn’s disease: results of the HOT-TOPIC trial after 1-year follow-up. United Eur Gastroenterol J 2022;10:160–168.CrossRef
Metadaten
Titel
Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis
verfasst von
Arafa Djalal
Serre-Yu Wong
Jean-Frédéric Colombel
Ryan Ungaro
Maia Kayal
Publikationsdatum
06.03.2024
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 4/2024
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08344-6

Weitere Artikel der Ausgabe 4/2024

Digestive Diseases and Sciences 4/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.